Repurposing an established drug: an emerging role for methylene blue in L-DOPA-induced dyskinesia

The European Journal of Neuroscience
Keila D Bariotto-Dos-SantosElaine Del Bel

Abstract

The nitric oxide (NO) system has been proven to be a valuable modulator of L-DOPA-induced dyskinesia in Parkinsonian rodents. NO activates the enzyme soluble guanylyl cyclase and elicits the synthesis of the second-messenger cGMP. Although we have previously described the anti-dyskinetic potential of NO synthase inhibitors on L-DOPA-induced dyskinesia, the effect of soluble guanylyl cyclase inhibitors remains to be evaluated. The aim of this study was to analyze whether the clinically available non-selective inhibitor methylene blue, or the selective soluble guanylyl cyclase inhibitor ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one), could mitigate L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats. Here, we demonstrated that methylene blue was able to reduce L-DOPA-induced dyskinesia incidence when chronically co-administered with L-DOPA during 3 weeks. Methylene blue chronic (but not acute) administration (2 weeks) was effective in attenuating L-DOPA-induced dyskinesia in rats rendered dyskinetic by a previous course of L-DOPA chronic treatment. Furthermore, discontinuous methylene blue treatment (e.g., co-administration of methylene blue and L-DOPA for 2 consecutive days followed by vehicle and L-DOPA co-administr...Continue Reading

References

Sep 23, 1994·Cell·C Nathan, Q W Xie
Aug 15, 1995·European Journal of Pharmacology·D LuoS R Vincent
Jun 1, 1993·Journal of Cardiovascular Pharmacology·D PayaJ C Stoclet
Apr 1, 1993·Pharmacology·S OktayB C Yegen
Feb 1, 1996·Acta Neurologica Scandinavica·J A MolinaJ Arenas
Apr 30, 1998·Journal of the Neurological Sciences·J A NavarroJ Arenas
Aug 22, 2000·European Journal of Clinical Pharmacology·C PeterB H Lauterburg
Oct 6, 2000·Nitric Oxide : Biology and Chemistry·E M GattoJ J Poderoso
May 2, 2001·Nature Reviews. Neuroscience·M F Beal
Dec 31, 1953·Acta Physiologica Scandinavica·K B AUGUSTINSSON, G HEIMBURGER
Mar 1, 1959·Japanese Journal of Pharmacology·R IMAIZUMIK INUI
Feb 6, 2004·European Journal of Pharmacology·Elaine A Del BelMarcela Bermúdez-Echeverry
Apr 6, 2004·The Journal of Comparative Neurology·Jin-Dong DingRichard J Weinberg
Aug 13, 2004·The European Journal of Neuroscience·Giuseppe SancesarioGiorgio Bernardi
Oct 7, 2004·Biochemical and Biophysical Research Communications·Malgorzata ChalimoniukJózef Marsala
Dec 23, 2004·Journal of Neural Transmission·J M BrotchieK Venderova
Mar 22, 2005·Biochemical Society Symposium·Dennis J StuehrElizabeth D Getzoff
Mar 29, 2005·European Journal of Pharmacology·Penny D RihaF Gonzalez-Lima
Jul 29, 2005·Cellular and Molecular Neurobiology·E A Del BelD de Paula-Souza
Aug 16, 2006·Neuro-degenerative Diseases·Evelyn BraungartMarius C Hoener
Sep 27, 2006·Handbook of Experimental Pharmacology·S Moncada, E A Higgs
Nov 10, 2006·The New England Journal of Medicine·Ferid Murad
Jul 1, 2008·The European Journal of Neuroscience·John Garthwaite
Aug 21, 2008·Nature Reviews. Neuroscience·Peter Jenner
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Jose A ObesoManuel Rodriguez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.